Tobacco Use Disorder Clinical Trial
Official title:
Modification of the Imbalance Between Goal-directed and Habitual Behavior in Human Addiction
Verified date | October 2023 |
Source | Central Institute of Mental Health, Mannheim |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study aims to examine the modification of the hypothesized imbalance between goal-directed and habitual behavior and its neural correlates in smokers. Two interventions will be used as add-on trainings to a smoking cessation program.
Status | Completed |
Enrollment | 75 |
Est. completion date | June 23, 2023 |
Est. primary completion date | June 23, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - severe tobacco use disorder (TUD) according to DSM-5 - sufficient ability to communicate with investigators and answer questions in both written and verbal format - ability to provide fully informed consent and to use self-rating scales Exclusion Criteria: - severe internal, neurological, and/or psychiatric comorbidities; other Axis I mental disorders other than TUD according to ICD-10 and DSM 5 (except for mild depression, i.e. F32.0, adjustment disorder and specific phobias) in the last 12 months - history of brain injury - severe physical diseases - common exclusion criteria for MRI (e.g. metal, claustrophobia) - positive drug screening (opioids, benzodiazepines, barbiturates, cocaine, amphetamines) - psychotropic medication within the last 14 days - pregnancy |
Country | Name | City | State |
---|---|---|---|
Germany | Klinik für Abhängiges Verhalten, Zentralinstitut für Seelische Gesundheit | Mannheim | Baden-Württemberg |
Lead Sponsor | Collaborator |
---|---|
Central Institute of Mental Health, Mannheim |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in imbalance between goal-directed and habitual behavior | measured by reward devaluation procedure (Hogarth & Chase 2011) | 2 time points: before and after 6 weeks SCP | |
Primary | Change in implicit smoking-related associations | smoking-related implicit association task (Wiers et al. 2016). | 3 time points: before and after 6 weeks SCP plus after 3 months | |
Primary | Change in attentional bias to smoking cues | smoking-related dot-probe task (Vollstädt-Klein et al. 2009). | 3 time points: before and after 6 weeks SCP plus after 3 months | |
Primary | Change in smoking urges | questionnaire of smoking urges (QSU, Müller et al. 2001)); self-report questionnaire; two subscales: "intention and desire to smoke / anticipation of pleasure from smoking" (range 11 - 77) and "anticipation of relief from negative affect and nicotine withdrawal / urgent and overwhelming desire to smoke" (range 10 - 70) high values represent high craving | 3 time points: before and after 6 weeks SCP plus after 3 months | |
Primary | Change in working memory capacity | Spatial Working Memory task from the Cambridge Automated Neuropsychological Test Automated Battery (Robbins et al. 1994) | 3 time points: before and after 6 weeks SCP plus after 3 months | |
Primary | Change in planning ability | One Touch Stockings of Cambridge task from the Cambridge Automated Neuropsychological Test Automated Battery (Robbins et al. 1994) | 3 time points: before and after 6 weeks SCP plus after 3 months | |
Primary | Change in cognitive flexibility | Internal-External Set Shifting task from the Cambridge Automated Neuropsychological Test Automated Battery (Robbins et al. 1994) | 3 time points: before and after 6 weeks SCP plus after 3 months | |
Secondary | nicotine consumption | self-report | 3 months follow-up | |
Secondary | Change in neural PIT effect | PIT phase of a choice task (adapted from Hogarth & Chase 2011) | 2 time points: before and after 6 weeks SCP | |
Secondary | Change in neural cue reactivity | fMRI cue-reactivity task (Vollstädt-Klein et al. 2011) | 2 time points: before and after 6 weeks SCP |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT02432066 -
Effects of GTS-21 on Smoking Behavior and Neurocognitive Functions
|
Phase 2 | |
Completed |
NCT03960138 -
Examining the Effects of Neural Stimulation on Inhibitory Control and Cigarette Smoking
|
N/A | |
Recruiting |
NCT05030272 -
Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings
|
N/A | |
Completed |
NCT04646668 -
Comparative Abuse Liability Among African American and White Smokers
|
N/A | |
Completed |
NCT02560324 -
Effect of Ramelteon on Smoking Abstinence
|
Phase 2 | |
Completed |
NCT02347605 -
Medicinal Nicotine for Preventing Cue Induced Craving
|
N/A | |
Completed |
NCT01570595 -
Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV
|
Phase 1/Phase 2 | |
Completed |
NCT01625767 -
Tobacco Approach Avoidance Training for Adolescent Smokers-1
|
Phase 2 | |
Completed |
NCT01428310 -
Study to Evaluate the Safety and Efficacy of Dietary Supplement Anatabloc in Reducing Daily Smokers' Urge to Smoke
|
Phase 1 | |
Terminated |
NCT01800500 -
Interest in Smokeless Tobacco Product as a Substitution for Cigarettes in Current Smokers
|
N/A | |
Completed |
NCT01442753 -
Family-Skills Training to Prevent Tobacco and Other Substance Use in Latino Youth
|
N/A | |
Active, not recruiting |
NCT01539525 -
Screening to Augment Referral to Treatment- Project START
|
Phase 2 | |
Completed |
NCT00967005 -
N-Acetyl Cysteine Plus Behavioral Therapy for Nicotine Dependent Pathological Gamblers
|
Phase 2 | |
Completed |
NCT01337817 -
A Pilot Study to Evaluate the Efficacy and Safety of Ariva® Silver Wintergreen in Healthy Smokers
|
Phase 1 | |
Active, not recruiting |
NCT00751660 -
Screening Methods in Finding Lung Cancer Early in Current or Former Smokers
|
N/A | |
Completed |
NCT00790569 -
Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking
|
N/A | |
Completed |
NCT00664261 -
Clinical Effort Against Secondhand Smoke (CEASE) Program or Standard Care in Helping Parents Stop Smoking
|
N/A | |
Completed |
NCT00218179 -
Assessing the Link Between Smoke Carcinogen Biomarkers and Lung Cancer Risk - 1
|
N/A | |
Completed |
NCT00134927 -
A Survey on Consumer Use of Over-the-Counter (OTC) Nicotine Patches
|
N/A | |
Completed |
NCT01213524 -
Nicotine and Sensorimotor Replacement for Smoking in Smokers With Schizophrenia
|
Phase 2 |